Common use of Address for Notice Clause in Contracts

Address for Notice. By:__________________________________________ Name: Xxxxxx Xxxxxxxxx Title: President and Chief Executive Officer With a copy to (which shall not constitute notice): 000 Xxxxxxxx Xxxxx, Xxxxx 000 Xxxxxxxxxxx, Xxxxxxxxxxxxx 00000 E-mail: xxxxxxxxxx@xxxxxxxxxx.xxx Xxxxx Lovells US LLP 0000 Xxxxxx Xxxxxx, Xxxxx 0000 Xxxxxxxxxxxx, XX 00000 Attn: Xxxxxx Xxxxxx, Esq. Email: xxxxx.xxxxxx@xxxxxxxxxxxx.xxx SIGNATURE PAGE FOR PURCHASER FOLLOWS] [PURCHASER SIGNATURE PAGES TO PHIO SECURITIES PURCHASE AGREEMENT] IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above. Name of Purchaser: ________________________________________________________ Signature of Authorized Signatory of Purchaser: __________________________________ Name of Authorized Signatory: ____________________________________________________ Title of Authorized Signatory: _____________________________________________________ Email Address of Authorized Signatory:______________________________________________ Address for Notice to Purchaser: Address for Delivery of Securities to Purchaser (if not same as address for notice): Subscription Amount: $_________________ Shares: _________________ Pre-Funded Warrants: __________________ Beneficial Ownership Blocker o 4.99% or o 9.99% Series A Common Warrants: __________________ Beneficial Ownership Blocker o 4.99% or o 9.99% Series B Common Warrants: __________________ Beneficial Ownership Blocker o 4.99% or o 9.99%

Address for Notice. By:__________________________________________ : 00X 0xx Xxxxxx, Xxx 0, AT# Carmel by the Xxx, XX, 00000 Name: Xxxxxx Xxxxxxxxx Xxxxxxx Xxxxxxx Email: xxxx@xxxxxxx.xxx Title: President and Chief Executive Officer With a copy to (which shall not constitute notice): 000 Xxxxxxxx Xxxxx, Xxxxx 000 Xxxxxxxxxxx, Xxxxxxxxxxxxx 00000 E-mail: xxxxxxxxxx@xxxxxxxxxx.xxx Xxxxx Lovells US Xxxxxxxx & Schole LLP 0000 Xxxxxx Xxxxxx, Xxxxx 0000 Xxxxxxxxxxxxxx xxx Xxxxxxxx Xxx Xxxx, XX 00000 AttnAttention: Xxxxxx Xxxxxxx X. Xxxxxx, Esq. Email: xxxxx.xxxxxx@xxxxxxxxxxxx.xxx xxxxxxx@xxxxxx.xxx [SIGNATURE PAGE FOR PURCHASER PURCHASERS FOLLOWS] [INNOVATIVE PAYMENT SOLUTIONS, INC. PURCHASER SIGNATURE PAGES PAGE TO PHIO SECURITIES PURCHASE AGREEMENT] AGREEMENT IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above. Name of Purchaser: _________________________________________________________________________ Signature of Authorized Signatory of Purchaser: __________________________________________________ Name of Authorized Signatory: ________________________________________________________________ Title of Authorized Signatory: _________________________________________________________________ Email Address of Authorized Signatory:: _________________________________________________________ Address for Notice to Purchaser: _______________________________________________________________ Address for Delivery of Securities to Purchaser (if not same as address for notice): ___________________________________________________________________________________________ Subscription Amount: $_________________ Shares: _________________ Pre-Funded WarrantsSocial Securiy/EIN Number: __________________ Beneficial Ownership Blocker o 4.99% or o 9.99% Series EXHIBIT A Common Warrants: __________________ Beneficial Ownership Blocker o 4.99% or o 9.99% Series Form of Note 23 EXHIBIT B Common Warrants: __________________ Beneficial Ownership Blocker o 4.99% or o 9.99%Form of Warrant

Address for Notice. 0000 XX Xxxxxx Xxxx. Xxxxxxxxx, XX 00000 By:__________________________________________ : Email: Name: Xxxxxx Xxxxxxxxx Fax: Title: President and Chief Executive Officer With a copy to (which shall not constitute notice): 000 [M. Xxx Xxxxxxxx Xxxxx, c/x Xxxxx 000 Xxxxxxxxxxx, Xxxxxxxxxxxxx 00000 E-mail: xxxxxxxxxx@xxxxxxxxxx.xxx Xxxxxxx LLP 0 Xxxxx Lovells US LLP 0000 Xxxxxx Xxxxxx, 00xx Xxxxx 0000 XxxxxxxxxxxxXxx Xxxx, XX 00000 Attn: Xxxxxx Xxxxxx, Esq. 000000 Email: xxxxx.xxxxxx@xxxxxxxxxxxx.xxx SIGNATURE PAGE FOR PURCHASER FOLLOWS] xxx.xxxxxxxx@xxxxxxxxxxxx.xxx]1 1 To be confirmed. 44 [PURCHASER SIGNATURE PAGES TO PHIO CROWN ELECTROKINETICS SECURITIES PURCHASE AGREEMENT] IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above. Name of Purchaser: ________________________________________________________ Signature of Authorized Signatory of Purchaser: __________________________________ Name of Authorized Signatory: ____________________________________________________ Title of Authorized Signatory: _____________________________________________________ Email Address of Authorized Signatory:: _____________________________________________ Facsimile Number of Authorized Signatory: __________________________________________ Address for Notice to Purchaser: Address for Delivery of Securities to Purchaser (if not same as address for notice): Subscription Amount: $_____________ Principal Amount: $_______________ Warrant Shares: _________________ Pre-Funded WarrantsEIN Number: __________________ Beneficial Ownership Blocker o 4.99% or o 9.99% Series A Common Warrants: __________________ Beneficial Ownership Blocker o 4.99% or o 9.99% Series B Common Warrants: __________________ Beneficial Ownership Blocker o 4.99% or o 9.99%

Address for Notice. By:__________________________________________ Name: Xxxxxx Xxxxxxxxx Xxxxxxxxx, Dr. Med. Sc. Title: President and Chief Executive Officer & CEO With a copy to (which shall not constitute notice): 000 Xxxxxxxx Xxxxx, Xxxxx 000 Xxxxxxxxxxx, Xxxxxxxxxxxxx 00000 Fax: 000-000-0000 E-mail: xxxxxxxxxx@xxxxxxxxxx.xxx Xxxxx Lovells US Xxxxxx, Xxxx & Xxxxxxxx, LLP 0000 Xxxxxx 000 Xxxxxxx Xxxxxx, Xxxxx 0000 XxxxxxxxxxxxXxx Xxxxxxxxx, XX Xxxxxxxxxx 00000 Attn: Xxxxxx Xxxxxx, Esq. Xxxx X. Xxxx Email: xxxxx.xxxxxx@xxxxxxxxxxxx.xxx xxxxx@xxxxxxxxxx.xxx SIGNATURE PAGE FOR PURCHASER FOLLOWS] [PURCHASER SIGNATURE PAGES TO PHIO SECURITIES PURCHASE AGREEMENT] IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above. Name of Purchaser: ________________________________________________________ Signature of Authorized Signatory of Purchaser: __________________________________ Name of Authorized Signatory: ____________________________________________________ Title of Authorized Signatory: _____________________________________________________ Email Address of Authorized Signatory:______________________________________________ Address for Notice to Purchaser: Address for Delivery of Securities to Purchaser (if not same as address for notice): Subscription Amount: $_________________ Shares: _________________ Pre-Funded Warrants: __________________ Beneficial Ownership Blocker o 4.99% or o 9.99% Series A Common Warrants: __________________ Beneficial Ownership Blocker o 4.99% or o 9.99% Series B Disclosure Schedules This Disclosure Schedule is made and given pursuant to Article 3 of the Securities Purchase Agreement, dated as of January 21, 2021 (the “Agreement”), between Phio Pharmaceuticals Corp., a Delaware corporation (the “Company”), and the Purchasers listed on the signature pages thereto. All capitalized terms used but not defined herein shall have the meanings as defined in the Agreement, unless otherwise provided. The section numbers below correspond to the section numbers of the representations and warranties in the Agreement. Nothing in this Disclosure Schedules is intended to broaden the scope of any representation or warranty contained in the Agreement or to create any covenant. Inclusion of any item in this Disclosure Schedules (1) does not represent a determination that such item is material or establish a standard of materiality, (2) does not represent a determination that such item did not arise in the ordinary course of business, (3) does not represent a determination that the transactions contemplated by the Agreement require the consent of third parties, and (4) shall not constitute, or be deemed to be, an admission to any third party concerning such item. This Disclosure Schedules includes brief descriptions or summaries of certain agreements and instruments, copies of which are available upon reasonable request. Schedule 3.1(a) MirImmune, LLC Schedule 3.1(g) Shares authorized: 100,000,000 Common Warrantsoutstanding: __________________ Beneficial Ownership Blocker o 4.99% or o 9.99%5,780,973 Non-affiliate Common outstanding: 5,744,440 Shares beneficially owned and of record by affiliates: 44,712 and 36,533 Schedule 3.1(i) None. Schedule 3.1(r) None Schedule 3.1(w) Registration Rights Agreement, dated August 7, 2019, by and between the Company and Lincoln Park Capital Fund, LLC. Schedule 3.1(bb) Paycheck Protection Program loan of $231,232 under the Coronavirus Aid, Relief, and Economic Security Act Schedule 4.7 The Company will be using the proceeds as listed in Section 4.7 of the Agreement.

Address for Notice. 100 Xxxxxxxx Xxxxxxxxx Xxxx., 0xx Xxxxx By:__________________________________________ : Bxxxxxxxxxx, Xxx Xxxxxx 00000 Name: Xxxxxx Xxxxxxxxx Title: President and Chief Executive Officer Email: dxxxxxxx@xxxxxxxxxx.xxx With a copy to (which shall not constitute notice): 000 Xxxxxxxx Xxxxx, Xxxxx 000 Xxxxxxxxxxx, Xxxxxxxxxxxxx 00000 E-mail: xxxxxxxxxx@xxxxxxxxxx.xxx Xxxxx Lovells US LLP 0000 Xxxxxx Xxxxxx, Xxxxx 0000 Xxxxxxxxxxxx, XX 00000 Axxxxx & Bird Attn: Xxxxxx Xxxxxx, Esq. Mxxxxxx Xxxxx Xxxxxxxxx: Email: xxxxx.xxxxxx@xxxxxxxxxxxx.xxx SIGNATURE PAGE FOR PURCHASER FOLLOWS] mxxxxxx.xxxxx@xxxxxx.xxx Acknowledged and agreed by: ZYVERSA THERAPEUTICS, INC. By: Name: Title: [PURCHASER SIGNATURE PAGES TO PHIO SECURITIES PURCHASE AGREEMENTLARSKPUR HEALTH ACQUISITION CORP. SPA] IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above. Name of Purchaser: ________________________________________________________ Signature of Authorized Signatory of Purchaser: __________________________________ Name of Authorized Signatory: ____________________________________________________ Title of Authorized Signatory: _____________________________________ Email Address of Authorized Signatory: ___________________________________________ Email Address of Authorized Signatoryfor Notice to Purchaser:_________________________________________________ Address for Notice to Purchaser: Address for Delivery of Securities to Purchaser (if not same as address for notice): Subscription Amount: $_________________ SharesShares of Preferred Stock: _________________ Pre-Funded WarrantsBeneficial Ownership Blocker ☐ 4.99% or ☐ 9.99% EIN Number: __________________ Beneficial Ownership Blocker o 4.99% or o 9.99% Series A Common Warrants: __________________ Beneficial Ownership Blocker o 4.99% or o 9.99% Series B Common Warrants: __________________ Beneficial Ownership Blocker o 4.99% or o 9.99%

Address for Notice. By:__________________________________________ : 00X 0xx Xxxxxx, Xxx 0, AT# Name: Xxxxxx Xxxxxxxxx Xxxxxxx Xxxxxxx Carmel by the Sea, CA, 93921 Title: President and Chief Executive Officer Email: xxxx@xxxxxxx.xxx With a copy to (which shall not constitute notice): 000 Xxxxxxxx Xxxxx, Xxxxx 000 Xxxxxxxxxxx, Xxxxxxxxxxxxx 00000 E-mail: xxxxxxxxxx@xxxxxxxxxx.xxx Xxxxx Lovells US Xxxxxxxx & Schole LLP 0000 Xxxxxx Xxxxxxxx xxx Xxxxxxxx New York, Xxxxx 0000 Xxxxxxxxxxxx, XX 00000 AttnNY 10105 Attention: Xxxxxx Xxxxxxx X. Xxxxxx, Esq. Email: xxxxx.xxxxxx@xxxxxxxxxxxx.xxx xxxxxxx@xxxxxx.xxx [SIGNATURE PAGE FOR PURCHASER PURCHASERS FOLLOWS] [INNOVATIVE PAYMENT SOLUTIONS, INC. PURCHASER SIGNATURE PAGES PAGE TO PHIO SECURITIES PURCHASE AGREEMENT] AGREEMENT IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above. Name of Purchaser: _________________________________________________________________________ Signature of Authorized Signatory of Purchaser: __________________________________________________ Name of Authorized Signatory: ________________________________________________________________ Title of Authorized Signatory: _________________________________________________________________ Email Address of Authorized Signatory:: _________________________________________________________ Address for Notice to Purchaser: _______________________________________________________________ Address for Delivery of Securities to Purchaser (if not same as address for notice): ___________________________________________________________________________________________ Subscription Amount: $_________________ Shares: _________________ Pre-Funded WarrantsSocial Securiy/EIN Number: __________________ Beneficial Ownership Blocker o 4.99% or o 9.99% Series EXHIBIT A Common Warrants: __________________ Beneficial Ownership Blocker o 4.99% or o 9.99% Series Form of Note 24 EXHIBIT B Common Warrants: __________________ Beneficial Ownership Blocker o 4.99% or o 9.99%Form of Warrant

Address for Notice. IRVINE SENSORS CORPORATION ------------------ 0000 Xxxxxxx Xxxxxx Xxxxx Xxxx, XX 00000 Tel: (000) 000-0000 By: /s/ Xxxx X. Xxxxxx, Xx. Fax: (000) 000-0000 ------------------------------------ Attn: Xxxx Xxxxxx Name: Xxxx X. Xxxxxx, Xx. Title: Sr. Vice President and Chief Financial Officer With copy to: ------------ XXXXXXX, PHLEGER & XXXXXXXX LLP 00 Xxxxxxxxxx Xxxxx Xxxxxx, XX 00000 Tel:(000) 000-0000 Fax:(000) 000-0000 Attn:_________________Xxxxx X. Xxxxxxxx, Esq. PURCHASERS: XXXXXXXXXXX X.X. Address for Notice: ------------------ 000 Xxxx Xxxxxx Xxxx. Xxxxx 000 By: /s/ Xxxxxxx Xxxxxxxxxxx Xxxxxxx, XX X0X 0X0 Xxxxxx _________________________ Attn: Fund Manager Name: Xxxxxx Xxxxxxxxx Xxxxxxx Xxxxxxxxxxx Subscription Amount:$900,000 Title: President and Chief Executive Officer With a copy to (which shall not constitute notice): 000 Xxxxxxxx Address for Notice: ------------------ ALPHA CAPITAL AG Xxxxxxxxxxx 00 Xxxxxxxxxx 0000 Xxxxx, Xxxxx Xxxxxxxxxxxxx By: /s/ Xxxxxx Xxxxxxxx Fax: 000-000 Xxxxxxxxxxx, Xxxxxxxxxxxxx 00000 E-mail: xxxxxxxxxx@xxxxxxxxxx.xxx Xxxxx Lovells US LLP 000 0000 Xxxxxx Xxxxxx, Xxxxx 0000 Xxxxxxxxxxxx, XX 00000 Attn: Xxxxxx Xxxxxx, Esq. Email: xxxxx.xxxxxx@xxxxxxxxxxxx.xxx SIGNATURE PAGE FOR PURCHASER FOLLOWS] [PURCHASER SIGNATURE PAGES TO PHIO SECURITIES PURCHASE AGREEMENT] IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above. Name of Purchaser: ________________________________________________________ Signature of Authorized Signatory of Purchaser: __________________________________ Name of Authorized Signatory: ____________________________________________________ Title of Authorized Signatory: _____________________________________________________ Email Address of Authorized Signatory:______________________________________________ Address for Notice to Purchaser: Address for Delivery of Securities to Purchaser (if not same as address for notice): Subscription Amount: $500,000 Name: Xxxxxx Xxxxxxxx Title: Director With notice to: -------------- XXXXXXX XXXXXXXXX LLP 00 Xxxx 00xx Xxxxxx Xxx Xxxx, Xxx Xxxx 00000-0000 Tel: (000) 000-0000 Fax: (000) 000-0000 Attn: Xxxxxx X. Xxxxxxx EXHIBIT A ESCROW AGREEMENT THIS ESCROW AGREEMENT (this "Agreement") is made as of May _________________ Shares: _________________ Pre-Funded Warrants: __________________ Beneficial Ownership Blocker o 4.99% or o 9.99% Series A Common Warrants: __________________ Beneficial Ownership Blocker o 4.99% or o 9.99% Series B Common Warrants: __________________ Beneficial Ownership Blocker o 4.99% or o 9.99%, 2002, by and among Irvine Sensors Corporation, a corporation incorporated under the laws of Delaware (the "Company"), the purchasers signatory hereto (each an "Purchaser" and together the "Purchasers"), and Xxxxxxx Xxxxxxxxx LLP, with an address at 00 Xxxx 00xx Xxxxxx, Xxx Xxxx, XX 00000 (the "Escrow Agent"). Capitalized terms used but not defined herein shall have the meanings set forth in the Securities Purchase Agreement referred to in the first recital.

Address for Notice. Intelligent Bio Solutions Inc. 100 Xxxx, 00xx Xxxxxx, 00xx Xxxxx Xxx Xxxx, XX 00000 Attn: Spiro Sakiris By:__________________________________________ : Email: sxxxx.xxxxxxx@xxx.xxx Name: Xxxxxx Xxxxxxxxx Sxxxx Xxxxxxx Title: President and Chief Executive Financial Officer With a copy to (which shall not constitute notice): 000 Xxxxxxxx XxxxxArent Fox Schiff LLP 1000 X Xxxxxx XX, Xxxxx 000 XxxxxxxxxxxXxxxxxxxxx, Xxxxxxxxxxxxx XX 00000 E-mail: xxxxxxxxxx@xxxxxxxxxx.xxx Xxxxx Lovells US LLP 0000 Xxxxxx Xxxxxx, Xxxxx 0000 Xxxxxxxxxxxx, XX 00000 rxxxx.xxxxxxxxx@xxxxxx.xxx Attn: Rxxxx Xx Xxxxxxx Jxxxxxxxx X. Xxxxxx Xxxxxx, Esq. Email: xxxxx.xxxxxx@xxxxxxxxxxxx.xxx SIGNATURE PAGE FOR PURCHASER FOLLOWS] [PURCHASER SIGNATURE PAGES TO PHIO INBS SECURITIES PURCHASE AGREEMENT] IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above. Name of Purchaser: _____________________________________________________________________________ Signature of Authorized Signatory of Purchaser: _______________________________________________________ Name of Authorized Signatory: _______________________________________________________________________ Title of Authorized Signatory: ________________________________________________________________________ Email Address of Authorized Signatory:: _________________________________________________________________ Address for Notice to Purchaser: Address for Delivery of Securities to Purchaser (if not same as address for notice): Subscription Amount: $_________________ Shares: _________________ Pre-Funded WarrantsBeneficial Ownership Blocker ☐ 4.99% or ☐ 9.99% Series H-1 Warrant Shares: ______________ Series H-2 Warrant Shares: __________________ Beneficial Ownership Blocker o 4.99% or o 9.99% Series A Common Warrants: I Warrant Shares (pre-funded warrants): __________________ Beneficial Ownership Blocker o 4.99% or o 9.99% Series B Common Warrants: __________________ Beneficial Ownership Blocker o 4.99% or o 9.99%)